1037-00007 · Solstice Biomedical Devices Ltd · Opinion

final-tax-opinion-letter.docx DOCUMENT M&A / Corporate

11 / 12 ← → ✕

Contract analysis Extract to table

CALDERWOOD & HARKNESS LLP Counselors at Law

599 Lexington Avenue, 36th Floor New York, NY 10022 United States

Telephone: (212) 558-4000 Facsimile: (212) 558-3588 www.calderwoodharkness.com

April 26, 2024

Matter No.: 1037-00007

VIA ELECTRONIC DELIVERY AND REGISTERED POST

The Board of Directors Solstice Biomedical Devices Ltd. Unit 14, Corrib Technology Park Headford Road Galway, H91 XR72 Ireland

PRIVILEGED AND CONFIDENTIAL ATTORNEY-CLIENT COMMUNICATION ATTORNEY WORK PRODUCT

I. INTRODUCTORY PARAGRAPH

Dear Members of the Board:

Calderwood & Harkness LLP ("C&H" or "we") has been engaged by Solstice Biomedical Devices Ltd. ("SBD" or the "Company"), an Irish private company limited by shares (Companies Registration Office ("CRO") No. 587241), to render this should-level tax opinion in connection with the proposed migration of certain intellectual property assets from Solstice Medical Technologies Inc. ("SMT Inc."), a Delaware C-corporation (Employer Identification Number ("EIN") 84-3291507; Delaware Secretary of State File No. 7482916), to Solstice IP Holdings Designated Activity Company ("SIP Holdings" or "SIPH"), an Irish designated activity company (CRO No. 714538), and the related intercompany licensing-back arrangement (collectively, the "Transaction"). Each of these entities is described in greater detail in Section IV below.

This opinion is delivered pursuant to the engagement letter dated February 9, 2024, between C&H and SBD (the "Engagement Letter"), and supersedes in its entirety the draft opinion letter circulated to the Board and management on April 10, 2024. To the extent of any inconsistency between this final opinion and the draft opinion previously circulated, this letter shall control.

The professionals responsible for this matter at C&H are as follows: Sylvia Hartwell, Partner (Tax), who serves as the responsible partner and signatory hereof; Leonard Cross, who serves as billing partner; Leila Nazari, who served as lead associate and was principally responsible for the legal research and initial drafting of this opinion; and Robert Jansen, who served as working associate and assisted with the factual investigation, document review, and computational analyses.

We have been informed, and we have confirmed through our review of the relevant board resolutions and related governance documents, that Pinnacle Growth Equity Partners Fund III, L.P. ("Pinnacle GEP III"), the majority shareholder of SBD holding approximately 62.3% of the Company's outstanding share capital, has provided board-level approval for the Transaction as required under SBD's shareholders' agreement and constitutional documents for material intercompany transactions exceeding €10,000,000 in value.

II. OPINION STANDARD

This opinion is rendered at the "should" level. As used herein, the term "should" means that, in our professional judgment, each tax position described in this opinion is one that "should" be sustained on its merits if properly raised and challenged by the applicable taxing authority — that is, we believe there is a greater than fifty percent (50%) likelihood that each such position would be sustained upon examination or in litigation on the merits, but we are unable to express the higher degree of confidence associated with a "will" opinion.

A "should" opinion represents our best professional judgment based on existing statutes, regulations, published rulings, judicial precedent, and administrative guidance in effect as of the date of this letter. A "should" opinion is distinguishable from a "will" opinion in that a "will" opinion reflects a level of confidence that the position is essentially free from doubt and would almost certainly be sustained if challenged. A "should" opinion is also distinguishable from a "more likely than not" opinion, which reflects only a confidence level that the position is more likely than not (i.e., greater than 50%) to be sustained but does not reflect the additional degree of confidence that typically accompanies a "should" opinion. A "should" opinion is generally understood in professional practice to convey a level of confidence materially higher than "more likely than not," and to indicate that the opining counsel believes the position is well-supported by the applicable authorities and should prevail on the merits, notwithstanding that some measure of uncertainty remains.

The law in this area — encompassing the United States federal income tax provisions, the United States-Ireland Income Tax Treaty, and the Irish tax provisions addressed herein — is complex and is subject to change. We can give no assurance that the law will not change, whether by legislative action, administrative pronouncement, or judicial decision, in a manner that would adversely affect the conclusions expressed in this opinion, and any such change could apply retroactively to the Transaction.

III. SCOPE OF OPINION

This opinion addresses the following United States federal income tax and Irish tax issues arising from the Transaction:

1. IRC § 367(d) — Outbound Transfer of Intangible Property. The application of Section 367(d) of the Internal Revenue Code of 1986, as amended (the "Code" or "IRC"), to the outbound transfer of the intellectual property portfolio (the "IP Portfolio") from SMT Inc. to SIP Holdings, including the availability of the useful-life election under Treasury Regulations Section 1.367(d)-1T(c)(3).

2. IRC § 482 — Arm's-Length Pricing. The arm's-length pricing of the IP transfer and the license-back royalty rate under Section 482 of the Code, including the "commensurate with income" standard applicable to transfers of intangible property.

3. IRC § 951A — Global Intangible Low-Taxed Income (GILTI). The GILTI implications with respect to royalty income earned by SIP Holdings and the availability (or unavailability) of the high-tax exclusion and the Section 250 deduction.

4. IRC § 952 — Subpart F Income. The Subpart F implications regarding potential characterization of royalty income as foreign personal holding company income under Section 954(c) of the Code.

5. IRC § 59A — Base Erosion and Anti-Abuse Tax (BEAT). The BEAT implications with respect to royalty payments from SMT Inc. to SIP Holdings, including calculation of the base erosion percentage.

6. US-Ireland Income Tax Treaty — Article 12 (Royalties). The withholding tax treatment of royalty payments under Article 12 of the Convention between the Government of the United States of America and the Government of Ireland for the Avoidance of Double Taxation and the Prevention of Fiscal Evasion with Respect to Taxes on Income and Capital Gains (the "Treaty" or the "US-Ireland Income Tax Treaty"), including the Limitation on Benefits provisions.

7. Section 291A TCA 1997 — Irish Capital Allowances. The qualification of the IP Portfolio for capital allowances (wear and tear allowances) under Section 291A of the Taxes Consolidation Act 1997 ("TCA 1997") as a "specified intangible asset."

8. Irish Transfer Pricing Compliance. Compliance with Irish transfer pricing rules as amended by the Finance Act 2019, as they apply to the intercompany IP transfer, the license-back arrangement, the intercompany loan, and the cost-plus R&D services agreement.

This opinion does not address state or local tax consequences in any United States jurisdiction, nor does it address non-US tax consequences other than the Irish tax issues specifically identified above. This opinion does not address the tax treatment of any person or entity other than the parties specifically identified herein, including, without limitation, the individual shareholders of SBD, the limited partners of Pinnacle GEP III, or any other affiliated or third-party entity.

This opinion does not address the securities law, corporate law, regulatory, or other non-tax legal aspects of the Transaction. We understand that SBD has retained Dalton Byrne & Partners (Séamus Dalton, Managing Partner) to advise on Irish corporate and intellectual property law matters relating to the Transaction, and that Harrington & Cahill (Niamh O'Sullivan, Tax Partner) serves as SBD's Irish tax advisors with respect to the Transaction.

IV. SUMMARY OF THE TRANSACTION

A. The Parties

1. Solstice Biomedical Devices Ltd. (SBD)

Solstice Biomedical Devices Ltd. is an Irish private company limited by shares, registered with the Companies Registration Office under CRO No. 587241. SBD's registered office is located at Unit 14, Corrib Technology Park, Headford Road, Galway, H91 XR72, Ireland. SBD's principal business activity is the design, manufacture, and distribution of minimally invasive cardiac catheter navigation systems and intra-operative imaging devices. For the fiscal year ended December 31, 2023 ("FY2023"), SBD reported consolidated revenue of approximately €347.6 million and consolidated earnings before interest, taxes, depreciation, and amortization ("EBITDA") of approximately €78.4 million, representing an EBITDA margin of approximately 22.5%. As of the date hereof, SBD employs approximately 1,640 employees worldwide across its facilities in Ireland, the United States, and other international locations.

SBD is privately held. Approximately 62.3% of SBD's outstanding share capital is held by Pinnacle Growth Equity Partners Fund III, L.P. ("Pinnacle GEP III"), a Delaware limited partnership. Pinnacle GEP III's general partner is Pinnacle Growth Equity Advisors III LLC, which is managed by Jonathan Whitfield, Managing Partner. Pinnacle GEP III has a total fund size of approximately $2.1 billion and is a 2019 vintage fund. Approximately 18.4% of SBD's share capital is held by Dr. Cathal Morrissey, the Founder and Chief Executive Officer of SBD, through Morrissey Family Holdings Unlimited Company (CRO No. 492103). Approximately 2.1% is held by Fiona Gallagher, the Chief Financial Officer of SBD. The remaining approximately 17.2% of SBD's share capital is held by other members of management and employees.

2. Solstice Medical Technologies Inc. (SMT Inc.)

Solstice Medical Technologies Inc. is a Delaware C-corporation with EIN 84-3291507 and Delaware Secretary of State File No. 7482916. SMT Inc.'s principal office is located at 2200 Biopharma Drive, Suite 300, Waltham, Massachusetts 02451. SMT Inc. is a wholly-owned subsidiary of SBD and is the current holder of the IP Portfolio that is the subject of this Transaction. SMT Inc. is responsible for research and development activities, United States regulatory submissions (including submissions to the Food and Drug Administration), and North American commercial operations for the SBD group. For FY2023, SMT Inc. reported revenue of approximately $189.2 million, representing approximately 50.1% of consolidated group revenues at the average FY2023 exchange rate of €1.00 = $1.09. SMT Inc. employs approximately 580 employees, primarily based at its Waltham, Massachusetts headquarters and at a research facility in San Diego, California. For FY2023, SMT Inc. reported total tax deductions of approximately $174.8 million, as confirmed by Lattimore & Stern CPAs LLP (David Lattimore, CPA), SMT Inc.'s US tax return preparer.

3. Solstice IP Holdings Designated Activity Company (SIP Holdings)

Solstice IP Holdings Designated Activity Company is an Irish designated activity company, registered with the Companies Registration Office under CRO No. 714538. SIP Holdings' registered office is located at Unit 14, Corrib Technology Park, Headford Road, Galway, H91 XR72, Ireland. SIP Holdings was incorporated on January 18, 2024, and has an authorized and issued share capital of €1,000 in ordinary shares, all of which are held by SBD. SIP Holdings is a newly incorporated entity that was established for the specific purpose of acquiring the IP Portfolio and licensing it back to SMT Inc. and other group entities. As of the date hereof, SIP Holdings has not yet conducted any business operations, and the Transaction will constitute its initial substantive commercial activity. SBD has represented to us that SIP Holdings will maintain genuine substance in Ireland, including management and control exercised from Ireland, qualified personnel with technical and commercial expertise, and appropriate infrastructure to manage the IP Portfolio.

B. The IP Portfolio

The IP Portfolio to be transferred in the Transaction consists of forty-seven (47) granted United States utility patents, twelve (12) pending United States patent applications, and associated trade secrets, technical know-how, engineering drawings, manufacturing process documentation, and proprietary software algorithms relating to SBD's "NaviPulse" catheter guidance platform and "ClearVue" intra-operative cardiac imaging system. The NaviPulse platform is SBD's core product line and comprises a suite of catheter navigation technologies used in minimally invasive cardiac procedures. The ClearVue system is an intra-operative cardiac imaging solution that provides real-time visualization during catheter-based interventions. Together, these technologies represent the principal value-driving intellectual property of the SBD group.

An independent valuation of the IP Portfolio was performed by Whitmore Valuation Advisors LLC ("WVA"), a United States-based transfer pricing and intellectual property valuation firm. The valuation engagement was conducted under WVA project reference WVA-2023-1187, with Marcus Whitmore, ASA, Managing Director, serving as the lead professional. WVA's office is located at 900 Third Avenue, 18th Floor, New York, NY 10022. The valuation was prepared as of a valuation date of December 31, 2023.

WVA determined that the fair market value of the IP Portfolio is $214.5 million, using the income approach (specifically, a discounted cash flow methodology) with a weighted average cost of capital ("WACC") of 13.5%. The IP Portfolio has a remaining weighted-average useful life of 12.8 years. SMT Inc.'s United States adjusted tax basis in the IP Portfolio, as reflected on SMT Inc.'s books and records, is $11.3 million, reflecting the fact that the IP has been substantially fully amortized or expensed for United States federal income tax purposes. Accordingly, the built-in gain for purposes of IRC § 367(d) is calculated as $214.5 million (fair market value) less $11.3 million (adjusted tax basis), yielding a built-in gain of $203.2 million.

C. Transaction Steps

The Transaction consists of the following integrated steps, each of which is described in the draft transaction documents reviewed by C&H:

Step 1: IP Acquisition. SIP Holdings will acquire the entire IP Portfolio from SMT Inc. pursuant to an IP Assignment Agreement for a purchase price of $214.5 million, reflecting the independently determined fair market value as of December 31, 2023. The purchase price will be funded through the following sources:

(a) An intercompany loan from SBD to SIP Holdings in the principal amount of €180.0 million (approximately $196.2 million at the prevailing spot rate at the time of the anticipated closing). The intercompany loan bears a fixed interest rate of 3.75% per annum, which has been independently benchmarked by WVA's intercompany debt pricing analysis and determined to be within an arm's-length range. The loan has a ten (10)-year term maturing on March 1, 2034. During years one through three, only interest payments are required. Commencing in year four and continuing through maturity, equal annual principal installments of approximately €25.71 million (calculated as €180.0 million divided by seven remaining years) will be payable, together with accrued interest. Annual interest on the full principal amount will be €6.75 million (€180.0 million × 3.75%).

(b) SIP Holdings equity of €1,000 (the initial share capital) plus a shareholder capital contribution from SBD to SIP Holdings in the amount of approximately €16.7 million, representing the balance of the purchase price after application of the intercompany loan proceeds.

Step 2: License-Back Agreement. Contemporaneously with the IP Acquisition, SIP Holdings will enter into an exclusive license-back agreement with SMT Inc. (the "License-Back Agreement"), pursuant to which SIP Holdings will grant to SMT Inc. the exclusive right to exploit the IP Portfolio in North America (the United States and Canada) in exchange for an arm's-length royalty of 8.0% of net sales, as determined by the WVA benchmarking analysis. Based on SMT Inc.'s FY2023 revenue of $189.2 million, the projected Year 1 royalty payment from SMT Inc. to SIP Holdings would be approximately $15.136 million ($189.2 million × 8.0%).

Step 3: Rest-of-World Licenses. SIP Holdings will enter into separate license agreements with SBD and other group entities for the exploitation of the IP Portfolio in territories outside of North America (the "Rest-of-World Licenses"). The royalty rates under these agreements range from 4.0% to 6.5% of net sales, depending on the specific territory and the value-added functions, assets employed, and risks assumed by the local licensee entity.

Step 4: Cost-Plus R&D Services Agreement. SMT Inc. will continue to perform contract research and development services for SIP Holdings under a cost-plus R&D services agreement (the "R&D Services Agreement"). Under this agreement, SMT Inc. will be compensated for its R&D services at cost plus an 8.0% mark-up. This arrangement ensures that SMT Inc. is appropriately compensated for its ongoing contributions to the development and enhancement of the IP Portfolio, while SIP Holdings, as the IP owner, will bear the economic risks and rewards associated with IP ownership, including the funding of R&D activities.

D. IP Value in EUR and Section 291A Capital Allowances

For purposes of the Irish capital allowances analysis, the IP Portfolio cost of $214.5 million, converted at the average FY2023 exchange rate of €1.00 = $1.09, yields a euro-denominated cost of approximately €196.8 million. Under Section 291A of TCA 1997, the statutory amortization period for capital allowances on specified intangible assets is fifteen (15) years. Accordingly, the annual capital allowance claimable by SIP Holdings would be approximately €13.12 million per year (€196.8 million ÷ 15 years), calculated on a straight-line basis over the statutory period.

V. DOCUMENTS AND MATERIALS REVIEWED

In connection with the preparation of this opinion, we have reviewed the following documents and materials (collectively, the "Reviewed Materials"):

1. Draft intellectual property valuation report prepared by Whitmore Valuation Advisors LLC, dated January 29, 2024, project reference WVA-2023-1187, authored by Marcus Whitmore, ASA, Managing Director.

2. Intercompany debt pricing analysis prepared by Whitmore Valuation Advisors LLC, in which WVA benchmarked the 3.75% fixed interest rate on the €180.0 million intercompany loan from SBD to SIP Holdings.

3. Factual Assumptions and Representations Letter from SBD to C&H, dated March 8, 2024, executed by Fiona Gallagher, Chief Financial Officer, and Dr. Cathal Morrissey, Chief Executive Officer (the "Factual Assumptions and Representations Letter" or the "Representations Letter").

4. Certificate of Incorporation and CRO filings for Solstice IP Holdings Designated Activity Company (CRO No. 714538; date of incorporation: January 18, 2024).

5. Draft IP Assignment Agreement by and between Solstice Medical Technologies Inc., as transferor, and Solstice IP Holdings DAC, as transferee, setting forth the terms of the transfer of the IP Portfolio for a purchase price of $214.5 million.

6. Draft License-Back Agreement by and between Solstice IP Holdings DAC, as licensor, and Solstice Medical Technologies Inc., as licensee, providing for an exclusive license for North America at a royalty rate of 8.0% of net sales.

7. Draft Rest-of-World License Agreements by and between Solstice IP Holdings DAC, as licensor, and various group entities, as licensees, providing for royalty rates ranging from 4.0% to 6.5% of net sales depending on territory.

8. Draft Cost-Plus R&D Services Agreement by and between Solstice Medical Technologies Inc., as service provider, and Solstice IP Holdings DAC, as service recipient, providing for compensation at cost plus an 8.0% mark-up.

9. Intercompany loan term sheet for the €180.0 million loan from SBD to SIP Holdings (3.75% fixed annual interest rate, 10-year term maturing March 1, 2034, interest-only payments for years 1–3, equal annual principal installments of approximately €25.71 million commencing year 4).

10. SBD consolidated audited financial statements for FY2023, audited by Pemberton Hale LLP (lead audit partner: Aisling Brennan).

11. SMT Inc. United States federal income tax returns and supporting schedules for the most recently filed taxable year and relevant prior periods.

12. SMT Inc. financial statements and supporting documentation showing an adjusted tax basis in the IP Portfolio of $11.3 million and total FY2023 deductions of $174.8 million.

13. Organizational charts for the SBD group, including the ownership structure of SBD, SMT Inc., SIP Holdings, and other affiliated entities.

14. United States patent portfolio schedule listing the 47 granted US utility patents and 12 pending US patent applications comprising the IP Portfolio.

15. Board resolutions of SBD and approval from Pinnacle GEP III in connection with the Transaction.

16. Correspondence with Harrington & Cahill (Niamh O'Sullivan, Tax Partner) regarding Irish tax compliance matters arising from the Transaction, including the availability of Section 291A capital allowances.

17. Correspondence with Dalton Byrne & Partners (Séamus Dalton, Managing Partner) regarding Irish corporate law and intellectual property matters relevant to the Transaction.

18. Correspondence with Lattimore & Stern CPAs LLP (David Lattimore, CPA) regarding SMT Inc. United States tax compliance data, including confirmation of the $174.8 million total deductions figure used in the BEAT analysis.

We have also reviewed such other documents, certificates, records, and materials as we have deemed necessary or appropriate for the purposes of rendering this opinion.

VI. FACTUAL ASSUMPTIONS AND REPRESENTATIONS

This opinion relies upon the factual assumptions and representations set forth in the Factual Assumptions and Representations Letter dated March 8, 2024, signed by Fiona Gallagher (CFO) and Dr. Cathal Morrissey (CEO), copies of which are in our files, as well as the following additional assumptions, each of which we have assumed to be true, correct, and complete for purposes of this opinion:

1. The $214.5 million purchase price reflects the fair market value of the IP Portfolio as of December 31, 2023, as independently determined by Whitmore Valuation Advisors LLC using the income approach (Discounted cash flow methodology) with a weighted average cost of capital of 13.5%. We have assumed that the WVA valuation was prepared in accordance with generally accepted valuation standards and that the financial projections, discount rates, and other inputs used in the valuation are reasonable and supportable.

2. The 8.0% royalty rate under the License-Back Agreement was independently benchmarked by WVA and reflects an arm's-length rate for comparable intellectual property licensing transactions involving medical device technology of a similar nature. The benchmarking analysis employed the comparable uncontrolled transaction method and the comparable profits method, and the selected royalty rate falls within the arm's-length range identified by WVA.

3. The IP Portfolio has a remaining weighted-average useful life of 12.8 years, as determined by WVA based on the remaining patent terms, the expected commercial life cycle of the underlying technologies, and the anticipated pace of technological obsolescence in the minimally invasive cardiac device market.

4. SIP Holdings will have genuine substance in Ireland, including management and control exercised in Ireland by directors and employees with appropriate qualifications and authority, qualified personnel with technical and commercial expertise to oversee the management and exploitation of the IP Portfolio, and a real business purpose for acquiring and managing the IP that is not solely or predominantly tax-motivated. SIP Holdings' central management and control will be situated in Ireland, and a majority of its directors will be Irish-resident.

5. The intercompany loan of €180.0 million from SBD to SIP Holdings at 3.75% fixed was priced on arm's-length terms, as confirmed by WVA's intercompany debt pricing analysis, which benchmarked the interest rate against comparable third-party lending arrangements involving borrowers of similar credit quality and loan characteristics.

6. SMT Inc.'s adjusted tax basis in the IP Portfolio is $11.3 million as of the date of the transfer, as reflected on SMT Inc.'s books and records and as confirmed by Lattimore & Stern CPAs LLP.

7. SMT Inc.'s FY2023 total deductions are $174.8 million, as confirmed by Lattimore & Stern CPAs LLP (David Lattimore, CPA). We have not independently audited or verified this figure.

8. The Transaction documents — including the IP Assignment Agreement, the License-Back Agreement, the Rest-of-World License Agreements, the Cost-Plus R&D Services Agreement, and the intercompany loan agreement — will be executed and consummated substantially in the form reviewed by C&H and summarized herein, without material modification.

9. No material change in applicable law — whether legislative, regulatory, administrative, or judicial — will occur between the date of this opinion and the closing and consummation of the Transaction.

10. All parties to the Transaction will comply with their respective reporting and filing obligations under applicable US and Irish tax law, including (without limitation) the filing of required information returns, treaty-based return position disclosures, and transfer pricing documentation.

11. SIP Holdings qualifies as a holder of "specified intangible assets" within the meaning of Section 291A of TCA 1997, and the IP Portfolio, when acquired by SIP Holdings, will constitute "specified intangible assets" eligible for capital allowances under that provision.

12. Board approval from Pinnacle GEP III was duly obtained in accordance with SBD's shareholders' agreement and constitutional documents, as the aggregate value of the Transaction exceeds the €10 million threshold for material intercompany transactions requiring prior approval from the holders of a majority of SBD's share capital.

We expressly note that if any of the foregoing factual assumptions or representations is inaccurate, incomplete, or changes in any material respect, the opinions expressed herein could be adversely affected, and this opinion should not be relied upon without our further review and, if appropriate, a supplemental or revised opinion letter.

VII. DISCUSSION AND ANALYSIS

A. IRC § 367(d) — Outbound Transfer of Intangible Property

1. General Rule. Section 367(d) of the Code addresses the United States federal income tax consequences of an outbound transfer of intangible property by a United States person to a foreign corporation. Under Section 367(d), when a United States person transfers "intangible property" (as defined in Section 936(h)(3)(B) of the Code) to a related foreign corporation in an exchange described in Sections 332, 351, 354, 356, or 361 of the Code, the United States transferor is treated as having sold the intangible property in exchange for payments that are contingent upon the productivity, use, or disposition of such property. These deemed payments are treated as received annually over the useful life of the intangible property (or, if no useful-life election is made, over a default 20-year period).

The policy underlying Section 367(d) is to prevent United States taxpayers from transferring valuable intangible property offshore to related foreign corporations — thereby removing the intangible property from the US taxing jurisdiction — without recognizing appropriate income. By imposing a deemed royalty inclusion, Section 367(d) ensures that the United States transferor continues to recognize income commensurate with the value of the transferred intangible property over its useful life, regardless of whether actual royalty payments are made by the foreign transferee.

The term "intangible property" for purposes of Section 367(d) is defined by reference to Section 936(h)(3)(B), which includes patents, inventions, formulae, processes, designs, patterns, know-how, copyrights, literary, musical, or artistic compositions, trademarks, trade names, brand names, franchises, licenses, contracts, methods, programs, systems, procedures, campaigns, surveys, studies, forecasts, estimates, customer lists, or technical data, and any similar item, the value or potential value of which is not attributable to tangible property or the services of any individual.

2. Application to the Transaction. The transfer of the IP Portfolio from SMT Inc. (a United States C-corporation and thus a "United States person" within the meaning of Section 7701(a)(30) of the Code) to SIP Holdings (a related Irish designated activity company and thus a "foreign corporation" within the meaning of Section 7701(a)(5) of the Code) constitutes an outbound transfer of intangible property within the meaning of Section 367(d). The IP Portfolio — comprising 47 granted US utility patents, 12 pending US patent applications, associated trade secrets, technical know-how, engineering drawings, manufacturing process documentation, and proprietary software algorithms — falls squarely within the definition of "intangible property" under Section 936(h)(3)(B). SMT Inc. and SIP Holdings are related corporations, as both are members of the same controlled group (SIP Holdings being 100% owned by SBD, which in turn is the 100% parent of SMT Inc.).

The transfer is structured as a sale for fair market value consideration ($214.5 million) rather than as a tax-free contribution under Section 351 of the Code. However, we note that Section 367(d) applies to any transfer of intangible property to a related foreign corporation in an exchange described in the enumerated Code sections, and the IRS may seek to recharacterize certain aspects of the Transaction if it determines that the economic substance of the transfer differs from its form. We have assumed that the Transaction will be respected in accordance with its form as a sale at fair market value.

The built-in gain on the IP Portfolio is calculated as follows:

Under Section 367(d), SMT Inc. would be treated as receiving deemed annual royalty payments commensurate with the income attributable to the transferred IP, spread over the useful life of the intangible property. Based on the WVA valuation, the remaining weighted-average useful life of the IP Portfolio is 12.8 years.

Treasury Regulations Section 1.367(d)-1T(c)(3) provides the United States transferor with an election to include deemed royalty amounts over the useful life of the transferred intangible property, as an alternative to the default 20-year inclusion period. Given that the IP Portfolio has a remaining weighted-average useful life of 12.8 years — substantially shorter than the 20-year default period — we believe it would be advisable for SMT Inc. to make the useful-life election. The useful-life election accelerates the recognition of deemed royalty income into a shorter period, but it has the benefit of aligning the deemed inclusions with the economic life of the IP and avoiding inclusions after the IP has become commercially obsolete or otherwise of diminished value. The aggregate amount of deemed income recognized over the inclusion period should be the same under either approach; however, the useful-life election more closely mirrors the actual economic reality of the IP Portfolio.

We have also considered the interplay between the Section 367(d) deemed royalty inclusion and the actual royalty payments to be received by SIP Holdings from SMT Inc. under the License-Back Agreement at 8.0% of net sales. The Section 367(d) deemed royalty inclusion applies to SMT Inc. as the US transferor of the intangible property, regardless of whether actual royalty payments flow in the other direction (i.e., from SMT Inc. to SIP Holdings). However, the regulations and relevant authorities indicate that the actual royalty payments received under the license-back arrangement may be taken into account in determining the amount of additional deemed inclusions, if any, required under Section 367(d). To the extent that the actual royalty payments from SMT Inc. to SIP Holdings are commensurate with the income attributable to the transferred IP, the deemed inclusion under Section 367(d) should be coordinated with the actual payments, thereby avoiding double counting.

We have also considered whether a gain recognition agreement under Treasury Regulations Section 1.367(d)-1T would be an advantageous alternative to the deemed royalty approach. Under a gain recognition agreement, the US transferor would defer gain recognition but agree to recognize the built-in gain if a triggering event occurs (such as a subsequent disposition of the intangible property by the foreign transferee). Based on our analysis of the facts, we conclude that the useful-life election is preferable to a gain recognition agreement in this case, given the substantial built-in gain of $203.2 million, the 12.8-year remaining useful life, and the ongoing License-Back Agreement that will generate actual royalty payments partially offsetting the deemed inclusions.

3. Opinion. Based on the foregoing analysis and subject to the assumptions, qualifications, and limitations set forth herein, it is our opinion at the should level that:

(a) The outbound transfer of the IP Portfolio from SMT Inc. to SIP Holdings should trigger deemed annual royalty inclusions to SMT Inc. under IRC § 367(d), calculated based on the $203.2 million built-in gain and spread over the remaining useful life of 12.8 years.

(b) The useful-life election under Treasury Regulations Section 1.367(d)-1T(c)(3) should be available to SMT Inc. and, if properly elected, should permit the deemed inclusions to be calculated over the 12.8-year useful life period rather than the default 20-year period.

(c) The actual royalty payments received by SMT Inc. under the License-Back Agreement should be taken into account in determining the amount of additional deemed inclusions, if any, required under Section 367(d), thereby coordinating the deemed inclusion mechanism with the actual intercompany royalty flow.

B. IRC § 482 — Arm's-Length Standard and Commensurate with Income

1. General Rule. Section 482 of the Code authorizes the Secretary of the Treasury to distribute, apportion, or allocate gross income, deductions, credits, or allowances among two or more organizations, trades, or businesses (whether or not incorporated, whether or not organized in the United States, and whether or not affiliated) owned or controlled directly or indirectly by the same interests, if the Secretary determines that such distribution, apportionment, or allocation is necessary in order to prevent evasion of taxes or clearly to reflect the income of any of such organizations, trades, or businesses.

The arm's-length standard is the foundational principle of Section 482. Under this standard, the results of a controlled transaction must be consistent with the results that would have been realized if uncontrolled taxpayers had engaged in the same transaction under the same circumstances. Treasury Regulations under Section 482 provide detailed methodologies for evaluating whether controlled transactions satisfy the arm's-length standard, including the comparable uncontrolled transaction method, the comparable profits method, the profit split method, and other specified methods.

Of particular relevance to the Transaction is the "commensurate with income" standard, which was added to Section 482 by the Tax Reform Act of 1986. This standard provides that, in the case of any transfer (or license) of intangible property, the income with respect to such transfer or license shall be commensurate with the income attributable to the intangible. The commensurate with income standard imposes an ongoing obligation: even if the initial pricing of an intangible property transfer is determined to be arm's-length, the IRS retains the authority to make periodic adjustments in subsequent years if the actual income attributable to the intangible deviates significantly from the income projected at the time of the transfer.

Treasury Regulations Section 1.482-4(f)(2) sets forth the rules governing periodic adjustments under the commensurate with income standard. Under these regulations, the IRS may make periodic adjustments if, in any taxable year, the actual profitability of the transferred intangible property is outside a range of reasonable expectations as of the date of the transfer.

2. Application to the Transaction. The $214.5 million purchase price for the IP Portfolio was independently determined by WVA using the income approach (Discounted cash flow methodology) as of December 31, 2023. The WVA valuation employed a WACC of 13.5%, which reflects the risk-adjusted cost of capital appropriate for a portfolio of medical device intellectual property of this nature. We have reviewed the WVA valuation report (project reference WVA-2023-1187) and are satisfied that the methodology employed and the key assumptions made are consistent with the transfer pricing standards set forth in Treasury Regulations Section 1.482-4 and the OECD Transfer Pricing Guidelines.

The 8.0% royalty rate under the License-Back Agreement was independently benchmarked by WVA using the comparable uncontrolled transaction ("CUT") method and the comparable profits method ("CPM"). WVA identified a set of comparable uncontrolled licensing transactions in the medical device and life sciences sectors, analyzed the key comparability factors (including the nature and scope of the licensed IP, the degree of exclusivity, the territory, the duration, and the relative bargaining positions of the parties), and determined that the 8.0% royalty rate falls within the arm's-length range. The projected Year 1 royalty payment under the License-Back Agreement would be $15.136 million ($189.2 million in FY2023 net sales × 8.0%).

In assessing whether the $214.5 million purchase price and the 8.0% royalty rate satisfy the commensurate with income standard, we note the following considerations:

(i) The WVA income-approach valuation is inherently forward-looking, incorporating projected future cash flows attributable to the IP Portfolio over its remaining useful life. The 13.5% WACC reflects appropriate risk factors, and the resulting $214.5 million valuation represents the present value of the expected income stream. To the extent that actual income deviates from projections, periodic adjustments under Treasury Regulations Section 1.482-4(f)(2) may be required.

(ii) The 8.0% royalty rate under the License-Back Agreement represents the ongoing price that SMT Inc. will pay for the right to exploit the IP in North America. This rate was independently benchmarked by WVA and falls within the range of royalty rates observed in comparable uncontrolled transactions. The royalty rate should be periodically reviewed and, if necessary, adjusted to ensure continued compliance with the commensurate with income standard as actual financial results become known.

(iii) The Cost-Plus R&D Services Agreement (cost plus 8.0% mark-up) provides a supporting element of economic substance. Under this arrangement, SMT Inc. is compensated for its ongoing R&D contributions at an arm's-length markup, while SIP Holdings — as the IP owner — bears the economic risks and rewards of IP ownership, including the funding of R&D through the service fee payments. This allocation of functions, assets, and risks is consistent with the transfer pricing standards and supports the overall arm's-length character of the Transaction.

3. Opinion. Based on the foregoing analysis and subject to the assumptions, qualifications, and limitations set forth herein, it is our opinion at the should level that:

(a) The $214.5 million purchase price for the IP Portfolio and the 8.0% royalty rate under the License-Back Agreement should satisfy the arm's-length standard under IRC § 482.

(b) The "commensurate with income" standard should be met based on the WVA income-approach valuation and benchmarking analysis, subject to the obligation to make periodic adjustments under Treasury Regulations Section 1.482-4(f)(2) if actual income attributable to the transferred IP deviates significantly from the income projected at the time of the transfer.

(c) We recommend that SBD and SMT Inc. maintain comprehensive, contemporaneous annual transfer pricing documentation and conduct periodic reviews of the 8.0% royalty rate in light of actual financial performance to ensure ongoing compliance with the commensurate with income standard.

C. IRC § 951A — Global Intangible Low-Taxed Income (GILTI)

1. General Rule. Section 951A of the Code, enacted as part of the Tax Cuts and Jobs Act of 2017, requires each United States shareholder (as defined in Section 951(b)) of a controlled foreign corporation ("CFC") (as defined in Section 957(a)) to include in gross income for each taxable year its "GILTI inclusion amount." The GILTI inclusion amount is determined as the excess of the US shareholder's pro rata share of the CFC's "tested income" over the US shareholder's "net deemed tangible income return." The net deemed tangible income return is computed as 10% of the US shareholder's pro rata share of the CFC's "qualified business asset investment" ("QBAI"), which is defined as the average of the CFC's aggregate adjusted bases in specified tangible property used in the production of tested income.

The GILTI regime is designed to impose a minimum level of current US taxation on the income of CFCs that exceeds a routine return on tangible assets, targeting income that is often attributable to intangible property held offshore. "Tested income" is defined as the excess of the CFC's gross income (other than income excluded under Section 951A(c)(2)) over properly allocable deductions. Certain categories of income are excluded from tested income, including income that is already subject to current US taxation under the Subpart F provisions (discussed in Section VII.D below), income effectively connected with a US trade or business, and certain other specified categories.

Under Section 250 of the Code, a domestic corporation that includes a GILTI amount in its income is entitled to a deduction equal to 50% of the GILTI inclusion (reduced to 37.5% for taxable years beginning after December 31, 2025). This deduction, combined with the indirect foreign tax credit available under Section 960 of the Code, is intended to result in an effective US tax rate on GILTI of approximately 10.5% (or 13.125% for post-2025 taxable years), before taking into account the foreign tax credits.

2. Application to the Transaction. SIP Holdings is a CFC for purposes of Section 957(a) of the Code, as it is 100% owned by SBD. Whether a GILTI inclusion is required depends on whether there are "United States shareholders" within the meaning of Section 951(b) who hold directly, indirectly, or constructively at least 10% of the voting power or value of SIP Holdings. SBD is itself an Irish company and is not a United States person. However, SBD's largest shareholder is Pinnacle GEP III, a Delaware limited partnership holding 62.3% of SBD's share capital. The partners of Pinnacle GEP III, to the extent they are US persons, may be treated as indirect US shareholders of SIP Holdings through the ownership chain: US person → Pinnacle GEP III (Delaware LP) → SBD (Irish company) → SIP Holdings (Irish DAC). The GILTI analysis thus depends on the identity and US-person status of the partners in Pinnacle GEP III, which we have assumed for purposes of this opinion includes US persons that may be treated as indirect US shareholders of SIP Holdings.

The royalty income earned by SIP Holdings under the License-Back Agreement and the Rest-of-World License Agreements should constitute "tested income" for GILTI purposes, unless such income is otherwise excluded from tested income by virtue of being characterized as Subpart F income under Section 952 (as discussed in Section VII.D below). If the royalty income is Subpart F income, it would be excluded from tested income but would instead be currently includible in the income of US shareholders under Section 951(a).

Regarding the QBAI offset, SIP Holdings' tangible depreciable assets are expected to be minimal, as the entity's principal asset is the IP Portfolio, which consists of intangible — not tangible — property. QBAI includes only the adjusted bases of specified tangible property (i.e., property of a character subject to depreciation under Section 167 of the Code), and therefore the IP Portfolio itself does not qualify as QBAI. SIP Holdings may acquire some tangible assets (such as office furniture, computers, and equipment), but these are expected to be de minimis in relation to the overall tested income. Accordingly, the QBAI offset is expected to provide only a negligible reduction in the GILTI inclusion amount, and substantially all of SIP Holdings' tested income (if not treated as Subpart F income) would be subject to GILTI.

We have also considered the availability of the high-tax exclusion under Treasury Regulations Section 1.951A-2(c)(7). The high-tax exclusion permits a CFC to exclude from tested income any item of income that is subject to an effective rate of foreign tax greater than 90% of the maximum US corporate tax rate. The current maximum US corporate tax rate is 21%, and 90% thereof is 18.9%. Ireland's headline corporate tax rate on trading income is 12.5%. Even after accounting for the Section 291A capital allowances (which will reduce taxable income but do not increase the effective tax rate above 12.5%), the effective Irish tax rate on SIP Holdings' royalty income is expected to remain at or below 12.5%, which is well below the 18.9% threshold. Accordingly, the high-tax exclusion should not be available to exclude SIP Holdings' royalty income from GILTI tested income.

However, the overall after-tax cost of the GILTI inclusion should be mitigated by the Section 250 deduction (50% or 37.5%, depending on the taxable year) and by indirect foreign tax credits under Section 960 of the Code with respect to Irish taxes paid by SIP Holdings. The net effect is that the GILTI regime imposes an incremental US tax cost on the royalty income, but this cost should be manageable and should not negate the overall tax efficiency of the Transaction structure.

3. Opinion. Based on the foregoing analysis and subject to the assumptions, qualifications, and limitations set forth herein, it is our opinion at the should level that:

(a) Royalty income earned by SIP Holdings should constitute tested income for GILTI purposes under IRC § 951A, to the extent such income is not otherwise characterized as Subpart F income under IRC § 952.

(b) GILTI inclusions should be required for US shareholders in the ownership chain (including US partners of Pinnacle GEP III who are indirect shareholders of SIP Holdings), subject to confirmation of the specific US-shareholder ownership analysis for each relevant US person.

(c) The QBAI exception should not meaningfully reduce the GILTI inclusion amount, given that SIP Holdings' principal asset is intangible property, which does not qualify as QBAI.

(d) The high-tax exclusion under Treasury Regulations Section 1.951A-2(c)(7) should not be available, given that Ireland's 12.5% corporate tax rate is below the 18.9% threshold (90% × 21%).

(e) The overall after-tax cost of the GILTI inclusion should be mitigated by the Section 250 deduction and by indirect foreign tax credits under Section 960, and the Transaction structure should remain tax-efficient on a net after-tax basis notwithstanding the GILTI exposure.

D. IRC § 952 — Subpart F / Foreign Personal Holding Company Income

1. General Rule. Under Section 952 of the Code, a US shareholder of a CFC must include in gross income its pro rata share of the CFC's "Subpart F income." Subpart F income is defined in Section 952(a) and includes, among other categories, "foreign base company income" as defined in Section 954(a). Foreign base company income, in turn, includes "foreign personal holding company income" ("FPHCI") as defined in Section 954(c).

FPHCI includes dividends, interest, rents, royalties, and annuities, as well as net gains from the sale or exchange of property that gives rise to such income. Of particular relevance to this Transaction, Section 954(c)(1)(A) provides that FPHCI includes royalties, including royalties received from related persons. A "related person" is defined in Section 954(d)(3) and includes a corporation that controls, or is controlled by, the CFC, or a corporation that is controlled by the same person or persons that control the CFC. SMT Inc., as a wholly-owned sister subsidiary of SIP Holdings within the SBD group, should be treated as a related person for these purposes.

The principal policy purpose of the Subpart F regime is to prevent US taxpayers from deferring US taxation on "passive" or "mobile" categories of income by accumulating such income in CFCs. By requiring current inclusion of FPHCI, the Subpart F rules ensure that royalty income earned by a CFC from related parties is subject to current US taxation, regardless of whether the income is distributed to the US shareholders.

2. Application to the Transaction. The royalty income received by SIP Holdings from SMT Inc. under the License-Back Agreement constitutes royalties received from a related person. As such, this income facially falls within the definition of FPHCI under Section 954(c)(1)(A) of the Code.

We have considered whether any exception to the FPHCI classification may apply:

Active Trade or Business Exception. Under certain circumstances, royalty income may be excluded from FPHCI if the CFC performs sufficient activities with respect to the intangible property that gives rise to the royalties. This exception generally requires that the CFC substantially creates, develops, or adds significant value to the intangible property through its own activities and personnel. While SIP Holdings will maintain substance in Ireland and will perform certain management and oversight functions with respect to the IP Portfolio, the IP was developed primarily by SMT Inc.'s R&D personnel in the United States. The extent to which SIP Holdings' activities rise to the level required for the active trade or business exception is uncertain, and we are unable to conclude at the should level that this exception would apply.

Same-Country Exception. Section 954(c)(3) provides a same-country exception that excludes from FPHCI certain royalties received from a related person organized and operating in the same foreign country as the CFC. This exception is not applicable here because the licensor (SIP Holdings, an Irish entity) and the licensee (SMT Inc., a Delaware corporation operating in the United States) are organized and operating in different countries.

Look-Through Rule Under § 954(c)(6). Section 954(c)(6) of the Code, when in effect, provides a "look-through" rule under which dividends, interest, rents, and royalties received from a related CFC are excluded from FPHCI to the extent attributable to income of the payor CFC that is neither Subpart F income nor income treated as effectively connected with the conduct of a trade or business in the United States. The look-through rule has historically been enacted and extended on a temporary basis. As of the date of this opinion, Section 954(c)(6) is in effect for taxable years of foreign corporations beginning before January 1, 2026. Whether Section 954(c)(6) will be extended beyond that date is uncertain and depends on future Congressional action. Moreover, the applicability of the look-through rule to the specific facts of this Transaction — including whether SMT Inc. is itself a CFC (it is a domestic corporation, not a CFC, so the look-through rule as written applies to payments between related CFCs and may not apply to royalties paid by a domestic corporation) — requires careful analysis. We note that the look-through rule under Section 954(c)(6) applies only to payments received or accrued from a "related person" that is itself a CFC. Because SMT Inc. is a domestic corporation and not a CFC, the Section 954(c)(6) look-through rule may not be available to exclude the royalties from FPHCI.

We have also considered the coordination between the Subpart F rules and the GILTI regime. Under Section 951A(c)(2)(A)(i), any income that is Subpart F income is excluded from GILTI tested income. Thus, to the extent the royalty income earned by SIP Holdings is characterized as Subpart F income (FPHCI), it would be currently includible in the US shareholders' income under Section 951(a) and would not also be subject to the GILTI inclusion. The practical difference is that Subpart F income is included at a 100% rate (subject to the foreign tax credit), whereas GILTI income benefits from the Section 250 deduction, resulting in an effective inclusion of only 50% (or 62.5% after 2025). Accordingly, Subpart F characterization may be less favorable than GILTI characterization from a pure rate perspective, although the interaction with foreign tax credits may moderate this difference.

3. Opinion. Based on the foregoing analysis and subject to the assumptions, qualifications, and limitations set forth herein, it is our opinion at the should level that:

(a) The royalty income received by SIP Holdings from SMT Inc. under the License-Back Agreement should be characterized as foreign personal holding company income under IRC § 954(c)(1)(A), unless an applicable exception applies.

(b) The Section 954(c)(6) look-through rule, even if currently in effect, may not be available to exclude the royalties from FPHCI, as the payor (SMT Inc.) is a domestic corporation and not a CFC. We recommend monitoring the status and scope of the look-through rule, including any future legislative extensions or modifications.

(c) To the extent the royalty income constitutes Subpart F income, it should be excluded from GILTI tested income under IRC § 951A(c)(2)(A)(i), and instead should be included in the US shareholders' income under IRC § 951(a).

(d) We recommend that SBD and its tax advisors carefully evaluate the interplay between Subpart F and GILTI characterization in connection with annual tax compliance and planning for the US shareholders.

E. IRC § 59A — Base Erosion and Anti-Abuse Tax (BEAT)

1. General Rule. Section 59A of the Code, enacted as part of the Tax Cuts and Jobs Act of 2017, imposes a minimum tax on "applicable taxpayers" — generally, corporations (other than regulated investment companies, real estate investment trusts, and S corporations) with average annual gross receipts of at least $500 million for the three-taxable-year period ending with the preceding taxable year, and with a "base erosion percentage" of 3% or more (or 2% or more for certain banks and registered securities dealers).

The BEAT operates by requiring an applicable taxpayer to pay a tax equal to the excess, if any, of the "base erosion minimum tax amount" (computed by applying the BEAT rate to the taxpayer's "modified taxable income") over the taxpayer's regular tax liability (reduced by certain credits). Modified taxable income is computed by adding back "base erosion tax benefits" — i.e., deductions attributable to "base erosion payments" — to regular taxable income.

A "base erosion payment" is defined in Section 59A(d) to include any amount paid or accrued by the taxpayer to a "related foreign person" (as defined in Section 59A(g)) that is deductible under the Code, including payments of royalties, interest, and service fees. The base erosion percentage is calculated as the aggregate base erosion tax benefits for the taxable year divided by the aggregate allowable deductions for the taxable year (with certain modifications specified in Section 59A(c)(4)).

The BEAT rate is 10% for taxable years beginning after December 31, 2018, and before January 1, 2026, and is scheduled to increase to 12.5% for taxable years beginning after December 31, 2025.

2. Application to the Transaction. We have analyzed whether SMT Inc. would be subject to the BEAT as a result of the royalty payments to SIP Holdings under the License-Back Agreement.

Gross Receipts Test. Whether SMT Inc. meets the $500 million average annual gross receipts test must be determined on an aggregated basis, taking into account the gross receipts of all persons treated as a single employer with SMT Inc. under Sections 52(a) and (b) of the Code. SBD's consolidated FY2023 revenue is €347.6 million (approximately $379 million at the €1.00 = $1.09 exchange rate). This figure is below the $500 million threshold when considered on a standalone basis for FY2023, but we note that the three-year average test requires analysis of the three preceding taxable years, and that gross receipts include all receipts of the aggregated group. We recommend that SBD and Lattimore & Stern CPAs LLP perform a detailed analysis of the gross receipts test on an aggregated basis. For purposes of this opinion, we have assumed that SMT Inc. meets or may meet the gross receipts test and have therefore analyzed the BEAT implications.

Base Erosion Percentage. The projected annual royalty payment from SMT Inc. to SIP Holdings under the License-Back Agreement is $15.136 million ($189.2 million in net sales × 8.0%). SMT Inc.'s FY2023 total deductions are $174.8 million, as confirmed by Lattimore & Stern CPAs LLP. The base erosion percentage is calculated as follows:

The resulting base erosion percentage of 8.66% exceeds the 3.0% statutory threshold. Accordingly, if SMT Inc. is an applicable taxpayer (having met the gross receipts test), it should be subject to potential BEAT liability.

Characterization of Royalty Payments as Base Erosion Payments. The royalty payments from SMT Inc. to SIP Holdings constitute amounts paid or accrued to a "related foreign person" — SIP Holdings is a foreign corporation that is a member of the same controlled group as SMT Inc. — and the royalty payments are deductible by SMT Inc. under Section 162 of the Code. Accordingly, these royalty payments should constitute "base erosion payments" within the meaning of Section 59A(d)(1), and the corresponding deductions should constitute "base erosion tax benefits" under Section 59A(c)(2).

BEAT Rate and Potential Exposure. Under the current BEAT rate structure, the BEAT rate is 10% for taxable years beginning before January 1, 2026, increasing to 12.5% thereafter. The potential BEAT liability for SMT Inc. would depend on the relationship between the BEAT minimum tax amount (computed by applying the BEAT rate to modified taxable income) and SMT Inc.'s regular tax liability. A full quantification of the BEAT exposure requires a comprehensive computation that is beyond the scope of this tax opinion and should be performed annually by Lattimore & Stern CPAs LLP in connection with the preparation of SMT Inc.'s US federal income tax return.

Potential Mitigants. We note the following potential mitigants that may reduce or manage the BEAT exposure:

(i) Cost-Plus R&D Service Payments. The Cost-Plus R&D Services Agreement provides for payments from SIP Holdings to SMT Inc. at cost plus 8.0%. These payments represent income

CALDERWOOD & HARKNESS LLP Counselors at Law
599 Lexington Avenue, 36th Floor New York, NY 10022 United States
Telephone: (212) 558-4000 Facsimile: (212) 558-3588 www.calderwoodharkness.com
April 26, 2024
Matter No.: 1037-00007
VIA ELECTRONIC DELIVERY AND REGISTERED POST
The Board of Directors Solstice Biomedical Devices Ltd. Unit 14, Corrib Technology Park Headford Road Galway, H91 XR72 Ireland
PRIVILEGED AND CONFIDENTIAL ATTORNEY-CLIENT COMMUNICATION ATTORNEY WORK PRODUCT
I. INTRODUCTORY PARAGRAPH
Dear Members of the Board:
Calderwood & Harkness LLP ("C&H" or "we") has been engaged by Solstice Biomedical Devices Ltd. ("SBD" or the "Company"), an Irish private company limited by shares (Companies Registration Office ("CRO") No. 587241), to render this should-level tax opinion in connection with the proposed migration of certain intellectual property assets from Solstice Medical Technologies Inc. ("SMT Inc."), a Delaware C-corporation (Employer Identification Number ("EIN") 84-3291507; Delaware Secretary of State File No. 7482916), to Solstice IP Holdings Designated Activity Company ("SIP Holdings" or "SIPH"), an Irish designated activity company (CRO No. 714538), and the related intercompany licensing-back arrangement (collectively, the "Transaction"). Each of these entities is described in greater detail in Section IV below.
This opinion is delivered pursuant to the engagement letter dated February 9, 2024, between C&H and SBD (the "Engagement Letter"), and supersedes in its entirety the draft opinion letter circulated to the Board and management on April 10, 2024. To the extent of any inconsistency between this final opinion and the draft opinion previously circulated, this letter shall control.
The professionals responsible for this matter at C&H are as follows: Sylvia Hartwell, Partner (Tax), who serves as the responsible partner and signatory hereof; Leonard Cross, who serves as billing partner; Leila Nazari, who served as lead associate and was principally responsible for the legal research and initial drafting of this opinion; and Robert Jansen, who served as working associate and assisted with the factual investigation, document review, and computational analyses.
We have been informed, and we have confirmed through our review of the relevant board resolutions and related governance documents, that Pinnacle Growth Equity Partners Fund III, L.P. ("Pinnacle GEP III"), the majority shareholder of SBD holding approximately 62.3% of the Company's outstanding share capital, has provided board-level approval for the Transaction as required under SBD's shareholders' agreement and constitutional documents for material intercompany transactions exceeding €10,000,000 in value.
II. OPINION STANDARD
This opinion is rendered at the "should" level. As used herein, the term "should" means that, in our professional judgment, each tax position described in this opinion is one that "should" be sustained on its merits if properly raised and challenged by the applicable taxing authority — that is, we believe there is a greater than fifty percent (50%) likelihood that each such position would be sustained upon examination or in litigation on the merits, but we are unable to express the higher degree of confidence associated with a "will" opinion.
A "should" opinion represents our best professional judgment based on existing statutes, regulations, published rulings, judicial precedent, and administrative guidance in effect as of the date of this letter. A "should" opinion is distinguishable from a "will" opinion in that a "will" opinion reflects a level of confidence that the position is essentially free from doubt and would almost certainly be sustained if challenged. A "should" opinion is also distinguishable from a "more likely than not" opinion, which reflects only a confidence level that the position is more likely than not (i.e., greater than 50%) to be sustained but does not reflect the additional degree of confidence that typically accompanies a "should" opinion. A "should" opinion is generally understood in professional practice to convey a level of confidence materially higher than "more likely than not," and to indicate that the opining counsel believes the position is well-supported by the applicable authorities and should prevail on the merits, notwithstanding that some measure of uncertainty remains.
The law in this area — encompassing the United States federal income tax provisions, the United States-Ireland Income Tax Treaty, and the Irish tax provisions addressed herein — is complex and is subject to change. We can give no assurance that the law will not change, whether by legislative action, administrative pronouncement, or judicial decision, in a manner that would adversely affect the conclusions expressed in this opinion, and any such change could apply retroactively to the Transaction.
III. SCOPE OF OPINION
This opinion addresses the following United States federal income tax and Irish tax issues arising from the Transaction:
1. IRC § 367(d) — Outbound Transfer of Intangible Property. The application of Section 367(d) of the Internal Revenue Code of 1986, as amended (the "Code" or "IRC"), to the outbound transfer of the intellectual property portfolio (the "IP Portfolio") from SMT Inc. to SIP Holdings, including the availability of the useful-life election under Treasury Regulations Section 1.367(d)-1T(c)(3).
2. IRC § 482 — Arm's-Length Pricing. The arm's-length pricing of the IP transfer and the license-back royalty rate under Section 482 of the Code, including the "commensurate with income" standard applicable to transfers of intangible property.
3. IRC § 951A — Global Intangible Low-Taxed Income (GILTI). The GILTI implications with respect to royalty income earned by SIP Holdings and the availability (or unavailability) of the high-tax exclusion and the Section 250 deduction.
4. IRC § 952 — Subpart F Income. The Subpart F implications regarding potential characterization of royalty income as foreign personal holding company income under Section 954(c) of the Code.
5. IRC § 59A — Base Erosion and Anti-Abuse Tax (BEAT). The BEAT implications with respect to royalty payments from SMT Inc. to SIP Holdings, including calculation of the base erosion percentage.
6. US-Ireland Income Tax Treaty — Article 12 (Royalties). The withholding tax treatment of royalty payments under Article 12 of the Convention between the Government of the United States of America and the Government of Ireland for the Avoidance of Double Taxation and the Prevention of Fiscal Evasion with Respect to Taxes on Income and Capital Gains (the "Treaty" or the "US-Ireland Income Tax Treaty"), including the Limitation on Benefits provisions.
7. Section 291A TCA 1997 — Irish Capital Allowances. The qualification of the IP Portfolio for capital allowances (wear and tear allowances) under Section 291A of the Taxes Consolidation Act 1997 ("TCA 1997") as a "specified intangible asset."
8. Irish Transfer Pricing Compliance. Compliance with Irish transfer pricing rules as amended by the Finance Act 2019, as they apply to the intercompany IP transfer, the license-back arrangement, the intercompany loan, and the cost-plus R&D services agreement.
This opinion does not address state or local tax consequences in any United States jurisdiction, nor does it address non-US tax consequences other than the Irish tax issues specifically identified above. This opinion does not address the tax treatment of any person or entity other than the parties specifically identified herein, including, without limitation, the individual shareholders of SBD, the limited partners of Pinnacle GEP III, or any other affiliated or third-party entity.
This opinion does not address the securities law, corporate law, regulatory, or other non-tax legal aspects of the Transaction. We understand that SBD has retained Dalton Byrne & Partners (Séamus Dalton, Managing Partner) to advise on Irish corporate and intellectual property law matters relating to the Transaction, and that Harrington & Cahill (Niamh O'Sullivan, Tax Partner) serves as SBD's Irish tax advisors with respect to the Transaction.
IV. SUMMARY OF THE TRANSACTION
A. The Parties
1. Solstice Biomedical Devices Ltd. (SBD)
Solstice Biomedical Devices Ltd. is an Irish private company limited by shares, registered with the Companies Registration Office under CRO No. 587241. SBD's registered office is located at Unit 14, Corrib Technology Park, Headford Road, Galway, H91 XR72, Ireland. SBD's principal business activity is the design, manufacture, and distribution of minimally invasive cardiac catheter navigation systems and intra-operative imaging devices. For the fiscal year ended December 31, 2023 ("FY2023"), SBD reported consolidated revenue of approximately €347.6 million and consolidated earnings before interest, taxes, depreciation, and amortization ("EBITDA") of approximately €78.4 million, representing an EBITDA margin of approximately 22.5%. As of the date hereof, SBD employs approximately 1,640 employees worldwide across its facilities in Ireland, the United States, and other international locations.
SBD is privately held. Approximately 62.3% of SBD's outstanding share capital is held by Pinnacle Growth Equity Partners Fund III, L.P. ("Pinnacle GEP III"), a Delaware limited partnership. Pinnacle GEP III's general partner is Pinnacle Growth Equity Advisors III LLC, which is managed by Jonathan Whitfield, Managing Partner. Pinnacle GEP III has a total fund size of approximately $2.1 billion and is a 2019 vintage fund. Approximately 18.4% of SBD's share capital is held by Dr. Cathal Morrissey, the Founder and Chief Executive Officer of SBD, through Morrissey Family Holdings Unlimited Company (CRO No. 492103). Approximately 2.1% is held by Fiona Gallagher, the Chief Financial Officer of SBD. The remaining approximately 17.2% of SBD's share capital is held by other members of management and employees.
2. Solstice Medical Technologies Inc. (SMT Inc.)
Solstice Medical Technologies Inc. is a Delaware C-corporation with EIN 84-3291507 and Delaware Secretary of State File No. 7482916. SMT Inc.'s principal office is located at 2200 Biopharma Drive, Suite 300, Waltham, Massachusetts 02451. SMT Inc. is a wholly-owned subsidiary of SBD and is the current holder of the IP Portfolio that is the subject of this Transaction. SMT Inc. is responsible for research and development activities, United States regulatory submissions (including submissions to the Food and Drug Administration), and North American commercial operations for the SBD group. For FY2023, SMT Inc. reported revenue of approximately $189.2 million, representing approximately 50.1% of consolidated group revenues at the average FY2023 exchange rate of €1.00 = $1.09. SMT Inc. employs approximately 580 employees, primarily based at its Waltham, Massachusetts headquarters and at a research facility in San Diego, California. For FY2023, SMT Inc. reported total tax deductions of approximately $174.8 million, as confirmed by Lattimore & Stern CPAs LLP (David Lattimore, CPA), SMT Inc.'s US tax return preparer.
3. Solstice IP Holdings Designated Activity Company (SIP Holdings)
Solstice IP Holdings Designated Activity Company is an Irish designated activity company, registered with the Companies Registration Office under CRO No. 714538. SIP Holdings' registered office is located at Unit 14, Corrib Technology Park, Headford Road, Galway, H91 XR72, Ireland. SIP Holdings was incorporated on January 18, 2024, and has an authorized and issued share capital of €1,000 in ordinary shares, all of which are held by SBD. SIP Holdings is a newly incorporated entity that was established for the specific purpose of acquiring the IP Portfolio and licensing it back to SMT Inc. and other group entities. As of the date hereof, SIP Holdings has not yet conducted any business operations, and the Transaction will constitute its initial substantive commercial activity. SBD has represented to us that SIP Holdings will maintain genuine substance in Ireland, including management and control exercised from Ireland, qualified personnel with technical and commercial expertise, and appropriate infrastructure to manage the IP Portfolio.
B. The IP Portfolio
The IP Portfolio to be transferred in the Transaction consists of forty-seven (47) granted United States utility patents, twelve (12) pending United States patent applications, and associated trade secrets, technical know-how, engineering drawings, manufacturing process documentation, and proprietary software algorithms relating to SBD's "NaviPulse" catheter guidance platform and "ClearVue" intra-operative cardiac imaging system. The NaviPulse platform is SBD's core product line and comprises a suite of catheter navigation technologies used in minimally invasive cardiac procedures. The ClearVue system is an intra-operative cardiac imaging solution that provides real-time visualization during catheter-based interventions. Together, these technologies represent the principal value-driving intellectual property of the SBD group.
An independent valuation of the IP Portfolio was performed by Whitmore Valuation Advisors LLC ("WVA"), a United States-based transfer pricing and intellectual property valuation firm. The valuation engagement was conducted under WVA project reference WVA-2023-1187, with Marcus Whitmore, ASA, Managing Director, serving as the lead professional. WVA's office is located at 900 Third Avenue, 18th Floor, New York, NY 10022. The valuation was prepared as of a valuation date of December 31, 2023.
WVA determined that the fair market value of the IP Portfolio is $214.5 million, using the income approach (specifically, a discounted cash flow methodology) with a weighted average cost of capital ("WACC") of 13.5%. The IP Portfolio has a remaining weighted-average useful life of 12.8 years. SMT Inc.'s United States adjusted tax basis in the IP Portfolio, as reflected on SMT Inc.'s books and records, is $11.3 million, reflecting the fact that the IP has been substantially fully amortized or expensed for United States federal income tax purposes. Accordingly, the built-in gain for purposes of IRC § 367(d) is calculated as $214.5 million (fair market value) less $11.3 million (adjusted tax basis), yielding a built-in gain of $203.2 million.
C. Transaction Steps
The Transaction consists of the following integrated steps, each of which is described in the draft transaction documents reviewed by C&H:
Step 1: IP Acquisition. SIP Holdings will acquire the entire IP Portfolio from SMT Inc. pursuant to an IP Assignment Agreement for a purchase price of $214.5 million, reflecting the independently determined fair market value as of December 31, 2023. The purchase price will be funded through the following sources:
(a) An intercompany loan from SBD to SIP Holdings in the principal amount of €180.0 million (approximately $196.2 million at the prevailing spot rate at the time of the anticipated closing). The intercompany loan bears a fixed interest rate of 3.75% per annum, which has been independently benchmarked by WVA's intercompany debt pricing analysis and determined to be within an arm's-length range. The loan has a ten (10)-year term maturing on March 1, 2034. During years one through three, only interest payments are required. Commencing in year four and continuing through maturity, equal annual principal installments of approximately €25.71 million (calculated as €180.0 million divided by seven remaining years) will be payable, together with accrued interest. Annual interest on the full principal amount will be €6.75 million (€180.0 million × 3.75%).
(b) SIP Holdings equity of €1,000 (the initial share capital) plus a shareholder capital contribution from SBD to SIP Holdings in the amount of approximately €16.7 million, representing the balance of the purchase price after application of the intercompany loan proceeds.
Step 2: License-Back Agreement. Contemporaneously with the IP Acquisition, SIP Holdings will enter into an exclusive license-back agreement with SMT Inc. (the "License-Back Agreement"), pursuant to which SIP Holdings will grant to SMT Inc. the exclusive right to exploit the IP Portfolio in North America (the United States and Canada) in exchange for an arm's-length royalty of 8.0% of net sales, as determined by the WVA benchmarking analysis. Based on SMT Inc.'s FY2023 revenue of $189.2 million, the projected Year 1 royalty payment from SMT Inc. to SIP Holdings would be approximately $15.136 million ($189.2 million × 8.0%).
Step 3: Rest-of-World Licenses. SIP Holdings will enter into separate license agreements with SBD and other group entities for the exploitation of the IP Portfolio in territories outside of North America (the "Rest-of-World Licenses"). The royalty rates under these agreements range from 4.0% to 6.5% of net sales, depending on the specific territory and the value-added functions, assets employed, and risks assumed by the local licensee entity.
Step 4: Cost-Plus R&D Services Agreement. SMT Inc. will continue to perform contract research and development services for SIP Holdings under a cost-plus R&D services agreement (the "R&D Services Agreement"). Under this agreement, SMT Inc. will be compensated for its R&D services at cost plus an 8.0% mark-up. This arrangement ensures that SMT Inc. is appropriately compensated for its ongoing contributions to the development and enhancement of the IP Portfolio, while SIP Holdings, as the IP owner, will bear the economic risks and rewards associated with IP ownership, including the funding of R&D activities.
D. IP Value in EUR and Section 291A Capital Allowances
For purposes of the Irish capital allowances analysis, the IP Portfolio cost of $214.5 million, converted at the average FY2023 exchange rate of €1.00 = $1.09, yields a euro-denominated cost of approximately €196.8 million. Under Section 291A of TCA 1997, the statutory amortization period for capital allowances on specified intangible assets is fifteen (15) years. Accordingly, the annual capital allowance claimable by SIP Holdings would be approximately €13.12 million per year (€196.8 million ÷ 15 years), calculated on a straight-line basis over the statutory period.
V. DOCUMENTS AND MATERIALS REVIEWED
In connection with the preparation of this opinion, we have reviewed the following documents and materials (collectively, the "Reviewed Materials"):
1. Draft intellectual property valuation report prepared by Whitmore Valuation Advisors LLC, dated January 29, 2024, project reference WVA-2023-1187, authored by Marcus Whitmore, ASA, Managing Director.
2. Intercompany debt pricing analysis prepared by Whitmore Valuation Advisors LLC, in which WVA benchmarked the 3.75% fixed interest rate on the €180.0 million intercompany loan from SBD to SIP Holdings.
3. Factual Assumptions and Representations Letter from SBD to C&H, dated March 8, 2024, executed by Fiona Gallagher, Chief Financial Officer, and Dr. Cathal Morrissey, Chief Executive Officer (the "Factual Assumptions and Representations Letter" or the "Representations Letter").
4. Certificate of Incorporation and CRO filings for Solstice IP Holdings Designated Activity Company (CRO No. 714538; date of incorporation: January 18, 2024).
5. Draft IP Assignment Agreement by and between Solstice Medical Technologies Inc., as transferor, and Solstice IP Holdings DAC, as transferee, setting forth the terms of the transfer of the IP Portfolio for a purchase price of $214.5 million.
6. Draft License-Back Agreement by and between Solstice IP Holdings DAC, as licensor, and Solstice Medical Technologies Inc., as licensee, providing for an exclusive license for North America at a royalty rate of 8.0% of net sales.
7. Draft Rest-of-World License Agreements by and between Solstice IP Holdings DAC, as licensor, and various group entities, as licensees, providing for royalty rates ranging from 4.0% to 6.5% of net sales depending on territory.
8. Draft Cost-Plus R&D Services Agreement by and between Solstice Medical Technologies Inc., as service provider, and Solstice IP Holdings DAC, as service recipient, providing for compensation at cost plus an 8.0% mark-up.
9. Intercompany loan term sheet for the €180.0 million loan from SBD to SIP Holdings (3.75% fixed annual interest rate, 10-year term maturing March 1, 2034, interest-only payments for years 1–3, equal annual principal installments of approximately €25.71 million commencing year 4).
10. SBD consolidated audited financial statements for FY2023, audited by Pemberton Hale LLP (lead audit partner: Aisling Brennan).
11. SMT Inc. United States federal income tax returns and supporting schedules for the most recently filed taxable year and relevant prior periods.
12. SMT Inc. financial statements and supporting documentation showing an adjusted tax basis in the IP Portfolio of $11.3 million and total FY2023 deductions of $174.8 million.
13. Organizational charts for the SBD group, including the ownership structure of SBD, SMT Inc., SIP Holdings, and other affiliated entities.
14. United States patent portfolio schedule listing the 47 granted US utility patents and 12 pending US patent applications comprising the IP Portfolio.
15. Board resolutions of SBD and approval from Pinnacle GEP III in connection with the Transaction.
16. Correspondence with Harrington & Cahill (Niamh O'Sullivan, Tax Partner) regarding Irish tax compliance matters arising from the Transaction, including the availability of Section 291A capital allowances.
17. Correspondence with Dalton Byrne & Partners (Séamus Dalton, Managing Partner) regarding Irish corporate law and intellectual property matters relevant to the Transaction.
18. Correspondence with Lattimore & Stern CPAs LLP (David Lattimore, CPA) regarding SMT Inc. United States tax compliance data, including confirmation of the $174.8 million total deductions figure used in the BEAT analysis.
We have also reviewed such other documents, certificates, records, and materials as we have deemed necessary or appropriate for the purposes of rendering this opinion.
VI. FACTUAL ASSUMPTIONS AND REPRESENTATIONS
This opinion relies upon the factual assumptions and representations set forth in the Factual Assumptions and Representations Letter dated March 8, 2024, signed by Fiona Gallagher (CFO) and Dr. Cathal Morrissey (CEO), copies of which are in our files, as well as the following additional assumptions, each of which we have assumed to be true, correct, and complete for purposes of this opinion:
1. The $214.5 million purchase price reflects the fair market value of the IP Portfolio as of December 31, 2023, as independently determined by Whitmore Valuation Advisors LLC using the income approach (Discounted cash flow methodology) with a weighted average cost of capital of 13.5%. We have assumed that the WVA valuation was prepared in accordance with generally accepted valuation standards and that the financial projections, discount rates, and other inputs used in the valuation are reasonable and supportable.
2. The 8.0% royalty rate under the License-Back Agreement was independently benchmarked by WVA and reflects an arm's-length rate for comparable intellectual property licensing transactions involving medical device technology of a similar nature. The benchmarking analysis employed the comparable uncontrolled transaction method and the comparable profits method, and the selected royalty rate falls within the arm's-length range identified by WVA.
3. The IP Portfolio has a remaining weighted-average useful life of 12.8 years, as determined by WVA based on the remaining patent terms, the expected commercial life cycle of the underlying technologies, and the anticipated pace of technological obsolescence in the minimally invasive cardiac device market.
4. SIP Holdings will have genuine substance in Ireland, including management and control exercised in Ireland by directors and employees with appropriate qualifications and authority, qualified personnel with technical and commercial expertise to oversee the management and exploitation of the IP Portfolio, and a real business purpose for acquiring and managing the IP that is not solely or predominantly tax-motivated. SIP Holdings' central management and control will be situated in Ireland, and a majority of its directors will be Irish-resident.
5. The intercompany loan of €180.0 million from SBD to SIP Holdings at 3.75% fixed was priced on arm's-length terms, as confirmed by WVA's intercompany debt pricing analysis, which benchmarked the interest rate against comparable third-party lending arrangements involving borrowers of similar credit quality and loan characteristics.
6. SMT Inc.'s adjusted tax basis in the IP Portfolio is $11.3 million as of the date of the transfer, as reflected on SMT Inc.'s books and records and as confirmed by Lattimore & Stern CPAs LLP.
7. SMT Inc.'s FY2023 total deductions are $174.8 million, as confirmed by Lattimore & Stern CPAs LLP (David Lattimore, CPA). We have not independently audited or verified this figure.
8. The Transaction documents — including the IP Assignment Agreement, the License-Back Agreement, the Rest-of-World License Agreements, the Cost-Plus R&D Services Agreement, and the intercompany loan agreement — will be executed and consummated substantially in the form reviewed by C&H and summarized herein, without material modification.
9. No material change in applicable law — whether legislative, regulatory, administrative, or judicial — will occur between the date of this opinion and the closing and consummation of the Transaction.
10. All parties to the Transaction will comply with their respective reporting and filing obligations under applicable US and Irish tax law, including (without limitation) the filing of required information returns, treaty-based return position disclosures, and transfer pricing documentation.
11. SIP Holdings qualifies as a holder of "specified intangible assets" within the meaning of Section 291A of TCA 1997, and the IP Portfolio, when acquired by SIP Holdings, will constitute "specified intangible assets" eligible for capital allowances under that provision.
12. Board approval from Pinnacle GEP III was duly obtained in accordance with SBD's shareholders' agreement and constitutional documents, as the aggregate value of the Transaction exceeds the €10 million threshold for material intercompany transactions requiring prior approval from the holders of a majority of SBD's share capital.
We expressly note that if any of the foregoing factual assumptions or representations is inaccurate, incomplete, or changes in any material respect, the opinions expressed herein could be adversely affected, and this opinion should not be relied upon without our further review and, if appropriate, a supplemental or revised opinion letter.
VII. DISCUSSION AND ANALYSIS
A. IRC § 367(d) — Outbound Transfer of Intangible Property
1. General Rule. Section 367(d) of the Code addresses the United States federal income tax consequences of an outbound transfer of intangible property by a United States person to a foreign corporation. Under Section 367(d), when a United States person transfers "intangible property" (as defined in Section 936(h)(3)(B) of the Code) to a related foreign corporation in an exchange described in Sections 332, 351, 354, 356, or 361 of the Code, the United States transferor is treated as having sold the intangible property in exchange for payments that are contingent upon the productivity, use, or disposition of such property. These deemed payments are treated as received annually over the useful life of the intangible property (or, if no useful-life election is made, over a default 20-year period).
The policy underlying Section 367(d) is to prevent United States taxpayers from transferring valuable intangible property offshore to related foreign corporations — thereby removing the intangible property from the US taxing jurisdiction — without recognizing appropriate income. By imposing a deemed royalty inclusion, Section 367(d) ensures that the United States transferor continues to recognize income commensurate with the value of the transferred intangible property over its useful life, regardless of whether actual royalty payments are made by the foreign transferee.
The term "intangible property" for purposes of Section 367(d) is defined by reference to Section 936(h)(3)(B), which includes patents, inventions, formulae, processes, designs, patterns, know-how, copyrights, literary, musical, or artistic compositions, trademarks, trade names, brand names, franchises, licenses, contracts, methods, programs, systems, procedures, campaigns, surveys, studies, forecasts, estimates, customer lists, or technical data, and any similar item, the value or potential value of which is not attributable to tangible property or the services of any individual.
2. Application to the Transaction. The transfer of the IP Portfolio from SMT Inc. (a United States C-corporation and thus a "United States person" within the meaning of Section 7701(a)(30) of the Code) to SIP Holdings (a related Irish designated activity company and thus a "foreign corporation" within the meaning of Section 7701(a)(5) of the Code) constitutes an outbound transfer of intangible property within the meaning of Section 367(d). The IP Portfolio — comprising 47 granted US utility patents, 12 pending US patent applications, associated trade secrets, technical know-how, engineering drawings, manufacturing process documentation, and proprietary software algorithms — falls squarely within the definition of "intangible property" under Section 936(h)(3)(B). SMT Inc. and SIP Holdings are related corporations, as both are members of the same controlled group (SIP Holdings being 100% owned by SBD, which in turn is the 100% parent of SMT Inc.).
The transfer is structured as a sale for fair market value consideration ($214.5 million) rather than as a tax-free contribution under Section 351 of the Code. However, we note that Section 367(d) applies to any transfer of intangible property to a related foreign corporation in an exchange described in the enumerated Code sections, and the IRS may seek to recharacterize certain aspects of the Transaction if it determines that the economic substance of the transfer differs from its form. We have assumed that the Transaction will be respected in accordance with its form as a sale at fair market value.
The built-in gain on the IP Portfolio is calculated as follows:
Under Section 367(d), SMT Inc. would be treated as receiving deemed annual royalty payments commensurate with the income attributable to the transferred IP, spread over the useful life of the intangible property. Based on the WVA valuation, the remaining weighted-average useful life of the IP Portfolio is 12.8 years.
Treasury Regulations Section 1.367(d)-1T(c)(3) provides the United States transferor with an election to include deemed royalty amounts over the useful life of the transferred intangible property, as an alternative to the default 20-year inclusion period. Given that the IP Portfolio has a remaining weighted-average useful life of 12.8 years — substantially shorter than the 20-year default period — we believe it would be advisable for SMT Inc. to make the useful-life election. The useful-life election accelerates the recognition of deemed royalty income into a shorter period, but it has the benefit of aligning the deemed inclusions with the economic life of the IP and avoiding inclusions after the IP has become commercially obsolete or otherwise of diminished value. The aggregate amount of deemed income recognized over the inclusion period should be the same under either approach; however, the useful-life election more closely mirrors the actual economic reality of the IP Portfolio.
We have also considered the interplay between the Section 367(d) deemed royalty inclusion and the actual royalty payments to be received by SIP Holdings from SMT Inc. under the License-Back Agreement at 8.0% of net sales. The Section 367(d) deemed royalty inclusion applies to SMT Inc. as the US transferor of the intangible property, regardless of whether actual royalty payments flow in the other direction (i.e., from SMT Inc. to SIP Holdings). However, the regulations and relevant authorities indicate that the actual royalty payments received under the license-back arrangement may be taken into account in determining the amount of additional deemed inclusions, if any, required under Section 367(d). To the extent that the actual royalty payments from SMT Inc. to SIP Holdings are commensurate with the income attributable to the transferred IP, the deemed inclusion under Section 367(d) should be coordinated with the actual payments, thereby avoiding double counting.
We have also considered whether a gain recognition agreement under Treasury Regulations Section 1.367(d)-1T would be an advantageous alternative to the deemed royalty approach. Under a gain recognition agreement, the US transferor would defer gain recognition but agree to recognize the built-in gain if a triggering event occurs (such as a subsequent disposition of the intangible property by the foreign transferee). Based on our analysis of the facts, we conclude that the useful-life election is preferable to a gain recognition agreement in this case, given the substantial built-in gain of $203.2 million, the 12.8-year remaining useful life, and the ongoing License-Back Agreement that will generate actual royalty payments partially offsetting the deemed inclusions.
3. Opinion. Based on the foregoing analysis and subject to the assumptions, qualifications, and limitations set forth herein, it is our opinion at the should level that:
(a) The outbound transfer of the IP Portfolio from SMT Inc. to SIP Holdings should trigger deemed annual royalty inclusions to SMT Inc. under IRC § 367(d), calculated based on the $203.2 million built-in gain and spread over the remaining useful life of 12.8 years.
(b) The useful-life election under Treasury Regulations Section 1.367(d)-1T(c)(3) should be available to SMT Inc. and, if properly elected, should permit the deemed inclusions to be calculated over the 12.8-year useful life period rather than the default 20-year period.
(c) The actual royalty payments received by SMT Inc. under the License-Back Agreement should be taken into account in determining the amount of additional deemed inclusions, if any, required under Section 367(d), thereby coordinating the deemed inclusion mechanism with the actual intercompany royalty flow.
B. IRC § 482 — Arm's-Length Standard and Commensurate with Income
1. General Rule. Section 482 of the Code authorizes the Secretary of the Treasury to distribute, apportion, or allocate gross income, deductions, credits, or allowances among two or more organizations, trades, or businesses (whether or not incorporated, whether or not organized in the United States, and whether or not affiliated) owned or controlled directly or indirectly by the same interests, if the Secretary determines that such distribution, apportionment, or allocation is necessary in order to prevent evasion of taxes or clearly to reflect the income of any of such organizations, trades, or businesses.
The arm's-length standard is the foundational principle of Section 482. Under this standard, the results of a controlled transaction must be consistent with the results that would have been realized if uncontrolled taxpayers had engaged in the same transaction under the same circumstances. Treasury Regulations under Section 482 provide detailed methodologies for evaluating whether controlled transactions satisfy the arm's-length standard, including the comparable uncontrolled transaction method, the comparable profits method, the profit split method, and other specified methods.
Of particular relevance to the Transaction is the "commensurate with income" standard, which was added to Section 482 by the Tax Reform Act of 1986. This standard provides that, in the case of any transfer (or license) of intangible property, the income with respect to such transfer or license shall be commensurate with the income attributable to the intangible. The commensurate with income standard imposes an ongoing obligation: even if the initial pricing of an intangible property transfer is determined to be arm's-length, the IRS retains the authority to make periodic adjustments in subsequent years if the actual income attributable to the intangible deviates significantly from the income projected at the time of the transfer.
Treasury Regulations Section 1.482-4(f)(2) sets forth the rules governing periodic adjustments under the commensurate with income standard. Under these regulations, the IRS may make periodic adjustments if, in any taxable year, the actual profitability of the transferred intangible property is outside a range of reasonable expectations as of the date of the transfer.
2. Application to the Transaction. The $214.5 million purchase price for the IP Portfolio was independently determined by WVA using the income approach (Discounted cash flow methodology) as of December 31, 2023. The WVA valuation employed a WACC of 13.5%, which reflects the risk-adjusted cost of capital appropriate for a portfolio of medical device intellectual property of this nature. We have reviewed the WVA valuation report (project reference WVA-2023-1187) and are satisfied that the methodology employed and the key assumptions made are consistent with the transfer pricing standards set forth in Treasury Regulations Section 1.482-4 and the OECD Transfer Pricing Guidelines.
The 8.0% royalty rate under the License-Back Agreement was independently benchmarked by WVA using the comparable uncontrolled transaction ("CUT") method and the comparable profits method ("CPM"). WVA identified a set of comparable uncontrolled licensing transactions in the medical device and life sciences sectors, analyzed the key comparability factors (including the nature and scope of the licensed IP, the degree of exclusivity, the territory, the duration, and the relative bargaining positions of the parties), and determined that the 8.0% royalty rate falls within the arm's-length range. The projected Year 1 royalty payment under the License-Back Agreement would be $15.136 million ($189.2 million in FY2023 net sales × 8.0%).
In assessing whether the $214.5 million purchase price and the 8.0% royalty rate satisfy the commensurate with income standard, we note the following considerations:
(i) The WVA income-approach valuation is inherently forward-looking, incorporating projected future cash flows attributable to the IP Portfolio over its remaining useful life. The 13.5% WACC reflects appropriate risk factors, and the resulting $214.5 million valuation represents the present value of the expected income stream. To the extent that actual income deviates from projections, periodic adjustments under Treasury Regulations Section 1.482-4(f)(2) may be required.
(ii) The 8.0% royalty rate under the License-Back Agreement represents the ongoing price that SMT Inc. will pay for the right to exploit the IP in North America. This rate was independently benchmarked by WVA and falls within the range of royalty rates observed in comparable uncontrolled transactions. The royalty rate should be periodically reviewed and, if necessary, adjusted to ensure continued compliance with the commensurate with income standard as actual financial results become known.
(iii) The Cost-Plus R&D Services Agreement (cost plus 8.0% mark-up) provides a supporting element of economic substance. Under this arrangement, SMT Inc. is compensated for its ongoing R&D contributions at an arm's-length markup, while SIP Holdings — as the IP owner — bears the economic risks and rewards of IP ownership, including the funding of R&D through the service fee payments. This allocation of functions, assets, and risks is consistent with the transfer pricing standards and supports the overall arm's-length character of the Transaction.
3. Opinion. Based on the foregoing analysis and subject to the assumptions, qualifications, and limitations set forth herein, it is our opinion at the should level that:
(a) The $214.5 million purchase price for the IP Portfolio and the 8.0% royalty rate under the License-Back Agreement should satisfy the arm's-length standard under IRC § 482.
(b) The "commensurate with income" standard should be met based on the WVA income-approach valuation and benchmarking analysis, subject to the obligation to make periodic adjustments under Treasury Regulations Section 1.482-4(f)(2) if actual income attributable to the transferred IP deviates significantly from the income projected at the time of the transfer.
(c) We recommend that SBD and SMT Inc. maintain comprehensive, contemporaneous annual transfer pricing documentation and conduct periodic reviews of the 8.0% royalty rate in light of actual financial performance to ensure ongoing compliance with the commensurate with income standard.
C. IRC § 951A — Global Intangible Low-Taxed Income (GILTI)
1. General Rule. Section 951A of the Code, enacted as part of the Tax Cuts and Jobs Act of 2017, requires each United States shareholder (as defined in Section 951(b)) of a controlled foreign corporation ("CFC") (as defined in Section 957(a)) to include in gross income for each taxable year its "GILTI inclusion amount." The GILTI inclusion amount is determined as the excess of the US shareholder's pro rata share of the CFC's "tested income" over the US shareholder's "net deemed tangible income return." The net deemed tangible income return is computed as 10% of the US shareholder's pro rata share of the CFC's "qualified business asset investment" ("QBAI"), which is defined as the average of the CFC's aggregate adjusted bases in specified tangible property used in the production of tested income.
The GILTI regime is designed to impose a minimum level of current US taxation on the income of CFCs that exceeds a routine return on tangible assets, targeting income that is often attributable to intangible property held offshore. "Tested income" is defined as the excess of the CFC's gross income (other than income excluded under Section 951A(c)(2)) over properly allocable deductions. Certain categories of income are excluded from tested income, including income that is already subject to current US taxation under the Subpart F provisions (discussed in Section VII.D below), income effectively connected with a US trade or business, and certain other specified categories.
Under Section 250 of the Code, a domestic corporation that includes a GILTI amount in its income is entitled to a deduction equal to 50% of the GILTI inclusion (reduced to 37.5% for taxable years beginning after December 31, 2025). This deduction, combined with the indirect foreign tax credit available under Section 960 of the Code, is intended to result in an effective US tax rate on GILTI of approximately 10.5% (or 13.125% for post-2025 taxable years), before taking into account the foreign tax credits.
2. Application to the Transaction. SIP Holdings is a CFC for purposes of Section 957(a) of the Code, as it is 100% owned by SBD. Whether a GILTI inclusion is required depends on whether there are "United States shareholders" within the meaning of Section 951(b) who hold directly, indirectly, or constructively at least 10% of the voting power or value of SIP Holdings. SBD is itself an Irish company and is not a United States person. However, SBD's largest shareholder is Pinnacle GEP III, a Delaware limited partnership holding 62.3% of SBD's share capital. The partners of Pinnacle GEP III, to the extent they are US persons, may be treated as indirect US shareholders of SIP Holdings through the ownership chain: US person → Pinnacle GEP III (Delaware LP) → SBD (Irish company) → SIP Holdings (Irish DAC). The GILTI analysis thus depends on the identity and US-person status of the partners in Pinnacle GEP III, which we have assumed for purposes of this opinion includes US persons that may be treated as indirect US shareholders of SIP Holdings.
The royalty income earned by SIP Holdings under the License-Back Agreement and the Rest-of-World License Agreements should constitute "tested income" for GILTI purposes, unless such income is otherwise excluded from tested income by virtue of being characterized as Subpart F income under Section 952 (as discussed in Section VII.D below). If the royalty income is Subpart F income, it would be excluded from tested income but would instead be currently includible in the income of US shareholders under Section 951(a).
Regarding the QBAI offset, SIP Holdings' tangible depreciable assets are expected to be minimal, as the entity's principal asset is the IP Portfolio, which consists of intangible — not tangible — property. QBAI includes only the adjusted bases of specified tangible property (i.e., property of a character subject to depreciation under Section 167 of the Code), and therefore the IP Portfolio itself does not qualify as QBAI. SIP Holdings may acquire some tangible assets (such as office furniture, computers, and equipment), but these are expected to be de minimis in relation to the overall tested income. Accordingly, the QBAI offset is expected to provide only a negligible reduction in the GILTI inclusion amount, and substantially all of SIP Holdings' tested income (if not treated as Subpart F income) would be subject to GILTI.
We have also considered the availability of the high-tax exclusion under Treasury Regulations Section 1.951A-2(c)(7). The high-tax exclusion permits a CFC to exclude from tested income any item of income that is subject to an effective rate of foreign tax greater than 90% of the maximum US corporate tax rate. The current maximum US corporate tax rate is 21%, and 90% thereof is 18.9%. Ireland's headline corporate tax rate on trading income is 12.5%. Even after accounting for the Section 291A capital allowances (which will reduce taxable income but do not increase the effective tax rate above 12.5%), the effective Irish tax rate on SIP Holdings' royalty income is expected to remain at or below 12.5%, which is well below the 18.9% threshold. Accordingly, the high-tax exclusion should not be available to exclude SIP Holdings' royalty income from GILTI tested income.
However, the overall after-tax cost of the GILTI inclusion should be mitigated by the Section 250 deduction (50% or 37.5%, depending on the taxable year) and by indirect foreign tax credits under Section 960 of the Code with respect to Irish taxes paid by SIP Holdings. The net effect is that the GILTI regime imposes an incremental US tax cost on the royalty income, but this cost should be manageable and should not negate the overall tax efficiency of the Transaction structure.
3. Opinion. Based on the foregoing analysis and subject to the assumptions, qualifications, and limitations set forth herein, it is our opinion at the should level that:
(a) Royalty income earned by SIP Holdings should constitute tested income for GILTI purposes under IRC § 951A, to the extent such income is not otherwise characterized as Subpart F income under IRC § 952.
(b) GILTI inclusions should be required for US shareholders in the ownership chain (including US partners of Pinnacle GEP III who are indirect shareholders of SIP Holdings), subject to confirmation of the specific US-shareholder ownership analysis for each relevant US person.
(c) The QBAI exception should not meaningfully reduce the GILTI inclusion amount, given that SIP Holdings' principal asset is intangible property, which does not qualify as QBAI.
(d) The high-tax exclusion under Treasury Regulations Section 1.951A-2(c)(7) should not be available, given that Ireland's 12.5% corporate tax rate is below the 18.9% threshold (90% × 21%).
(e) The overall after-tax cost of the GILTI inclusion should be mitigated by the Section 250 deduction and by indirect foreign tax credits under Section 960, and the Transaction structure should remain tax-efficient on a net after-tax basis notwithstanding the GILTI exposure.
D. IRC § 952 — Subpart F / Foreign Personal Holding Company Income
1. General Rule. Under Section 952 of the Code, a US shareholder of a CFC must include in gross income its pro rata share of the CFC's "Subpart F income." Subpart F income is defined in Section 952(a) and includes, among other categories, "foreign base company income" as defined in Section 954(a). Foreign base company income, in turn, includes "foreign personal holding company income" ("FPHCI") as defined in Section 954(c).
FPHCI includes dividends, interest, rents, royalties, and annuities, as well as net gains from the sale or exchange of property that gives rise to such income. Of particular relevance to this Transaction, Section 954(c)(1)(A) provides that FPHCI includes royalties, including royalties received from related persons. A "related person" is defined in Section 954(d)(3) and includes a corporation that controls, or is controlled by, the CFC, or a corporation that is controlled by the same person or persons that control the CFC. SMT Inc., as a wholly-owned sister subsidiary of SIP Holdings within the SBD group, should be treated as a related person for these purposes.
The principal policy purpose of the Subpart F regime is to prevent US taxpayers from deferring US taxation on "passive" or "mobile" categories of income by accumulating such income in CFCs. By requiring current inclusion of FPHCI, the Subpart F rules ensure that royalty income earned by a CFC from related parties is subject to current US taxation, regardless of whether the income is distributed to the US shareholders.
2. Application to the Transaction. The royalty income received by SIP Holdings from SMT Inc. under the License-Back Agreement constitutes royalties received from a related person. As such, this income facially falls within the definition of FPHCI under Section 954(c)(1)(A) of the Code.
We have considered whether any exception to the FPHCI classification may apply:
Active Trade or Business Exception. Under certain circumstances, royalty income may be excluded from FPHCI if the CFC performs sufficient activities with respect to the intangible property that gives rise to the royalties. This exception generally requires that the CFC substantially creates, develops, or adds significant value to the intangible property through its own activities and personnel. While SIP Holdings will maintain substance in Ireland and will perform certain management and oversight functions with respect to the IP Portfolio, the IP was developed primarily by SMT Inc.'s R&D personnel in the United States. The extent to which SIP Holdings' activities rise to the level required for the active trade or business exception is uncertain, and we are unable to conclude at the should level that this exception would apply.
Same-Country Exception. Section 954(c)(3) provides a same-country exception that excludes from FPHCI certain royalties received from a related person organized and operating in the same foreign country as the CFC. This exception is not applicable here because the licensor (SIP Holdings, an Irish entity) and the licensee (SMT Inc., a Delaware corporation operating in the United States) are organized and operating in different countries.
Look-Through Rule Under § 954(c)(6). Section 954(c)(6) of the Code, when in effect, provides a "look-through" rule under which dividends, interest, rents, and royalties received from a related CFC are excluded from FPHCI to the extent attributable to income of the payor CFC that is neither Subpart F income nor income treated as effectively connected with the conduct of a trade or business in the United States. The look-through rule has historically been enacted and extended on a temporary basis. As of the date of this opinion, Section 954(c)(6) is in effect for taxable years of foreign corporations beginning before January 1, 2026. Whether Section 954(c)(6) will be extended beyond that date is uncertain and depends on future Congressional action. Moreover, the applicability of the look-through rule to the specific facts of this Transaction — including whether SMT Inc. is itself a CFC (it is a domestic corporation, not a CFC, so the look-through rule as written applies to payments between related CFCs and may not apply to royalties paid by a domestic corporation) — requires careful analysis. We note that the look-through rule under Section 954(c)(6) applies only to payments received or accrued from a "related person" that is itself a CFC. Because SMT Inc. is a domestic corporation and not a CFC, the Section 954(c)(6) look-through rule may not be available to exclude the royalties from FPHCI.
We have also considered the coordination between the Subpart F rules and the GILTI regime. Under Section 951A(c)(2)(A)(i), any income that is Subpart F income is excluded from GILTI tested income. Thus, to the extent the royalty income earned by SIP Holdings is characterized as Subpart F income (FPHCI), it would be currently includible in the US shareholders' income under Section 951(a) and would not also be subject to the GILTI inclusion. The practical difference is that Subpart F income is included at a 100% rate (subject to the foreign tax credit), whereas GILTI income benefits from the Section 250 deduction, resulting in an effective inclusion of only 50% (or 62.5% after 2025). Accordingly, Subpart F characterization may be less favorable than GILTI characterization from a pure rate perspective, although the interaction with foreign tax credits may moderate this difference.
3. Opinion. Based on the foregoing analysis and subject to the assumptions, qualifications, and limitations set forth herein, it is our opinion at the should level that:
(a) The royalty income received by SIP Holdings from SMT Inc. under the License-Back Agreement should be characterized as foreign personal holding company income under IRC § 954(c)(1)(A), unless an applicable exception applies.
(b) The Section 954(c)(6) look-through rule, even if currently in effect, may not be available to exclude the royalties from FPHCI, as the payor (SMT Inc.) is a domestic corporation and not a CFC. We recommend monitoring the status and scope of the look-through rule, including any future legislative extensions or modifications.
(c) To the extent the royalty income constitutes Subpart F income, it should be excluded from GILTI tested income under IRC § 951A(c)(2)(A)(i), and instead should be included in the US shareholders' income under IRC § 951(a).
(d) We recommend that SBD and its tax advisors carefully evaluate the interplay between Subpart F and GILTI characterization in connection with annual tax compliance and planning for the US shareholders.
E. IRC § 59A — Base Erosion and Anti-Abuse Tax (BEAT)
1. General Rule. Section 59A of the Code, enacted as part of the Tax Cuts and Jobs Act of 2017, imposes a minimum tax on "applicable taxpayers" — generally, corporations (other than regulated investment companies, real estate investment trusts, and S corporations) with average annual gross receipts of at least $500 million for the three-taxable-year period ending with the preceding taxable year, and with a "base erosion percentage" of 3% or more (or 2% or more for certain banks and registered securities dealers).
The BEAT operates by requiring an applicable taxpayer to pay a tax equal to the excess, if any, of the "base erosion minimum tax amount" (computed by applying the BEAT rate to the taxpayer's "modified taxable income") over the taxpayer's regular tax liability (reduced by certain credits). Modified taxable income is computed by adding back "base erosion tax benefits" — i.e., deductions attributable to "base erosion payments" — to regular taxable income.
A "base erosion payment" is defined in Section 59A(d) to include any amount paid or accrued by the taxpayer to a "related foreign person" (as defined in Section 59A(g)) that is deductible under the Code, including payments of royalties, interest, and service fees. The base erosion percentage is calculated as the aggregate base erosion tax benefits for the taxable year divided by the aggregate allowable deductions for the taxable year (with certain modifications specified in Section 59A(c)(4)).
The BEAT rate is 10% for taxable years beginning after December 31, 2018, and before January 1, 2026, and is scheduled to increase to 12.5% for taxable years beginning after December 31, 2025.
2. Application to the Transaction. We have analyzed whether SMT Inc. would be subject to the BEAT as a result of the royalty payments to SIP Holdings under the License-Back Agreement.
Gross Receipts Test. Whether SMT Inc. meets the $500 million average annual gross receipts test must be determined on an aggregated basis, taking into account the gross receipts of all persons treated as a single employer with SMT Inc. under Sections 52(a) and (b) of the Code. SBD's consolidated FY2023 revenue is €347.6 million (approximately $379 million at the €1.00 = $1.09 exchange rate). This figure is below the $500 million threshold when considered on a standalone basis for FY2023, but we note that the three-year average test requires analysis of the three preceding taxable years, and that gross receipts include all receipts of the aggregated group. We recommend that SBD and Lattimore & Stern CPAs LLP perform a detailed analysis of the gross receipts test on an aggregated basis. For purposes of this opinion, we have assumed that SMT Inc. meets or may meet the gross receipts test and have therefore analyzed the BEAT implications.
Base Erosion Percentage. The projected annual royalty payment from SMT Inc. to SIP Holdings under the License-Back Agreement is $15.136 million ($189.2 million in net sales × 8.0%). SMT Inc.'s FY2023 total deductions are $174.8 million, as confirmed by Lattimore & Stern CPAs LLP. The base erosion percentage is calculated as follows:
The resulting base erosion percentage of 8.66% exceeds the 3.0% statutory threshold. Accordingly, if SMT Inc. is an applicable taxpayer (having met the gross receipts test), it should be subject to potential BEAT liability.
Characterization of Royalty Payments as Base Erosion Payments. The royalty payments from SMT Inc. to SIP Holdings constitute amounts paid or accrued to a "related foreign person" — SIP Holdings is a foreign corporation that is a member of the same controlled group as SMT Inc. — and the royalty payments are deductible by SMT Inc. under Section 162 of the Code. Accordingly, these royalty payments should constitute "base erosion payments" within the meaning of Section 59A(d)(1), and the corresponding deductions should constitute "base erosion tax benefits" under Section 59A(c)(2).
BEAT Rate and Potential Exposure. Under the current BEAT rate structure, the BEAT rate is 10% for taxable years beginning before January 1, 2026, increasing to 12.5% thereafter. The potential BEAT liability for SMT Inc. would depend on the relationship between the BEAT minimum tax amount (computed by applying the BEAT rate to modified taxable income) and SMT Inc.'s regular tax liability. A full quantification of the BEAT exposure requires a comprehensive computation that is beyond the scope of this tax opinion and should be performed annually by Lattimore & Stern CPAs LLP in connection with the preparation of SMT Inc.'s US federal income tax return.
Potential Mitigants. We note the following potential mitigants that may reduce or manage the BEAT exposure:
(i) Cost-Plus R&D Service Payments. The Cost-Plus R&D Services Agreement provides for payments from SIP Holdings to SMT Inc. at cost plus 8.0%. These payments represent income

CALDERWOOD & HARKNESS LLP Counselors at Law

VIA ELECTRONIC DELIVERY AND REGISTERED POST

PRIVILEGED AND CONFIDENTIAL ATTORNEY-CLIENT COMMUNICATION ATTORNEY WORK PRODUCT

I. INTRODUCTORY PARAGRAPH

II. OPINION STANDARD

III. SCOPE OF OPINION

IV. SUMMARY OF THE TRANSACTION

V. DOCUMENTS AND MATERIALS REVIEWED

VI. FACTUAL ASSUMPTIONS AND REPRESENTATIONS

VII. DISCUSSION AND ANALYSIS

Record

Parties

Dates

Amounts